News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) (JOBS) to Stop European Sales of Diet Drug Sold Under the Names Reductil, Reduxade and Zelium in Europe and Meridia in the United States


1/22/2010 6:45:22 AM

Bookmark and Share

Reuters -- Abbott Laboratories (ABT.N) said on Thursday it will suspend European sales of a weight- loss pill in the face of a recommendation by regulators that heart-related risks made the prescription drug too dangerous.

Read at Reuters
Read at News Release
Read at Wall Street Journal


comments powered by Disqus
Abbott
 
 
Obesity

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES